Leuprorelin Ovarian function | Search results | NICE

Showing 1 result for leuprorelin ovarian function

Sort by

Olaparib for previously treated BRCA mutation-positive hormone-relapsed metastatic prostate cancer (TA887)
Evidence-based recommendations on olaparib (Lynparza) for previously treated BRCA mutation-positive hormone-relapsed metastatic prostate cancer in adults.
Result type
Technology appraisal guidance
Published
10 May 2023
View recommendations for TA887
Show all sections
Sections for TA887